APLS vs MSFT: Which Stock is Better?
Side-by-side comparison of Apellis Pharmaceuticals Inc and Microsoft Corporation in 2026
APLS
Apellis Pharmaceuticals Inc
—
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | APLS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.29B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze APLS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APLS or MSFT a better investment?
Comparing APLS and MSFT: Apellis Pharmaceuticals Inc has a market cap of $2.29B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APLS and MSFT?
APLS (Apellis Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APLS or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APLS or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for APLS.
Which company is more profitable: APLS or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for APLS.
Which is the larger company: APLS or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $2.29B for APLS.
Should I buy APLS or MSFT in 2026?
Both APLS and MSFT have investment merit. APLS trades at $N/A while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APLS and MSFT stock?
Key differences: Market Cap ($2.29B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy APLS or MSFT in 2026?
The choice between APLS and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between APLS and MSFT?
APLS (Apellis Pharmaceuticals Inc) has a market cap of $2.29B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.